NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $10.96 +0.04 (+0.32%) Closing price 06/26/2026 03:59 PM EasternExtended Trading$11.00 +0.04 (+0.41%) As of 06/26/2026 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Core Laboratories Stock (NYSE:CLB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Core Laboratories alerts:Sign Up Key Stats Today's Range$10.57▼$11.0350-Day Range$10.78▼$17.4652-Week Range$9.72▼$20.36Volume1.52 million shsAverage Volume654,948 shsMarket Capitalization$505.03 millionP/E Ratio16.85Dividend Yield0.37%Price Target$12.00Consensus RatingReduce Company Overview Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets. The company’s portfolio spans two primary service lines: reservoir description and production enhancement. In reservoir description, Core Laboratories performs detailed analyses on drill-cuttings, cores and reservoir fluids to characterize rock and fluid properties. Under production enhancement, the company offers well stimulation, downhole chemistry, and scale and corrosion management solutions designed to improve flow rates and mitigate operational risks. These services are supported by a global network of research laboratories and field service centers equipped with advanced instrumentation. Headquartered in Amsterdam with key operating offices in Houston, Core Laboratories conducts business in more than 50 countries across six continents, serving major international and national oil companies, as well as independents. The company’s engineering and technical teams collaborate closely with clients to tailor solutions to diverse reservoir environments. Under the leadership of President and CEO Clay C. Williams, Core Laboratories continues to invest in innovation and technology development to address evolving challenges in reservoir management and production optimization.AI Generated. May Contain Errors. Read More Core Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreCLB MarketRank™: Core Laboratories scored higher than 53% of companies evaluated by MarketBeat, and ranked 167th out of 252 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.8 / 5Analyst RatingReduce Consensus RatingCore Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Core Laboratories is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageCore Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth44.64% Earnings GrowthEarnings for Core Laboratories are expected to grow by 44.64% in the coming year, from $0.56 to $0.81 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 16.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.22.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 16.85, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 18.96.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 2.11. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.16% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 9.58.Change versus previous monthShort interest in Core Laboratories has recently decreased by 3.04%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.37%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 6.15%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 4.94% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. News and Social MediaN/ANews SentimentN/A Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by Insiders1.26% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLB Stock News HeadlinesCore Laboratories (NYSE:CLB) Upgraded by Wall Street Zen to "Hold" RatingJune 20, 2026 | americanbankingnews.comNoble Corporation, Valaris, and Core Laboratories shares plummet, what you need to knowJune 16, 2026 | msn.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.June 27 at 1:00 AM | Stansberry Research (Ad)Core Laboratories and Helmerich & Payne shares are soaring, what you need to knowJune 10, 2026 | msn.comTETRA Technologies and Core Laboratories shares skyrocket, what you need to knowJune 8, 2026 | msn.comWinners and losers of Q1: Core Laboratories (NYSE:CLB) vs the rest of the oilfield services stocksJune 5, 2026 | msn.comThese 10 small-cap energy stocks carry the market's least attractive valuationsJune 2, 2026 | seekingalpha.comCore Laboratories Shareholders Back Directors, Auditor and PayMay 13, 2026 | tipranks.comSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $16.02 at the beginning of 2026. Since then, CLB stock has decreased by 31.6% and is now trading at $10.9550. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) released its quarterly earnings data on Wednesday, April, 29th. The oil and gas company reported $0.06 earnings per share for the quarter, hitting the consensus estimate of $0.06. The company's revenue was down 1.4% compared to the same quarter last year. Read the conference call transcript. Who are Core Laboratories' major shareholders? Core Laboratories' top institutional shareholders include Dimensional Fund Advisors LP (2.93%), Bank of New York Mellon Corp (0.88%), Principal Financial Group Inc. (0.59%) and Bank of America Corp DE (0.49%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings4/29/2026Record date for 6/1 Dividend5/11/2026Ex-Dividend for 6/1 Dividend5/11/2026Dividend Payable6/01/2026Today6/27/2026Next Earnings (Estimated)7/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 For the last 11 days, CLB's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorEnergy Industry OIL - FIELD SVCS Sub-IndustryPetroleum And Natural Gas Current SymbolNYSE:CLB CIK1958086 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,300Year Founded1936Price Target and Rating Average Price Target for Core Laboratories$12.00 High Price Target$12.00 Low Price Target$12.00 Potential Upside/Downside+9.5%Consensus RatingReduce Rating Score (0-4)1.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.65 Trailing P/E Ratio16.85 Forward P/E Ratio19.56 P/E Growth2.13Net Income$29.67 million Net Margins5.94% Pretax Margin8.21% Return on Equity11.52% Return on Assets5.32% Debt Debt-to-Equity Ratio0.42 Current Ratio2.05 Quick Ratio1.50 Sales & Book Value Annual Sales$526.52 million Price / Sales0.96 Cash Flow$1.06 per share Price / Cash Flow10.32 Book Value$5.85 per share Price / Book1.87Miscellaneous Outstanding Shares46,100,000Free Float45,516,000Market Cap$505.03 million OptionableOptionable Beta0.98 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NYSE:CLB) was last updated on 6/27/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLB Stock Alerts